CLINICAL TRIALS PROFILE FOR ULORIC

All Clinical Trials for ULORIC

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00102440 ↗	Febuxostat Versus Allopurinol Control Trial in Subjects With Gout	Completed	Takeda	Phase 3	2002-07-01	The purpose of this study is to evaluate the safety and efficacy of febuxostat, once daily (QD), versus allopurinol in subjects with gout.
NCT00174915 ↗	Phase 3, Febuxostat, Allopurinol and Placebo-Controlled Study in Gout Subjects.	Completed	Takeda	Phase 3	2003-02-01	The purpose of this study is to compare febuxostat, allopurinol and placebo, once daily (QD), in subjects with gout.
NCT00174941 ↗	Long-Term Safety of Febuxostat in Subjects With Gout.	Completed	Takeda	Phase 2	2001-03-01	The purpose of this study is to evaluate the long-term safety of febuxostat, once daily (QD), in maintaining serum urate levels within clinically acceptable levels in subjects with gout.
NCT00174967 ↗	Dose-Response, Safety and Efficacy of Febuxostat in Subjects With Gout	Completed	Takeda	Phase 2	2001-01-01	The purpose of this study is to determine the efficacy of febuxostat, once daily (QD), in reducing serum urate levels in subjects with gout.
NCT00175019 ↗	Allopurinol Versus Febuxostat in Subjects Completing the Phase 3 Trials C02-009 or C02-010	Completed	Takeda	Phase 3	2003-07-01	The purpose of this study is to determine the long-term safety of febuxostat, once daily (QD), compared to allopurinol in reducing serum urate levels in subjects with gout.
NCT00430248 ↗	Efficacy and Safety of Oral Febuxostat in Participants With Gout	Completed	Takeda	Phase 3	2007-02-01	The purpose of this study is to compare the efficacy and safety of febuxostat, once Daily (QD), to allopurinol in subjects with hyperuricemia and gout.

Clinical Trial Conditions for ULORIC

Condition Name

Condition Name for ULORIC
Intervention	Trials
Gout	14
Hyperuricemia	5
Chronic Kidney Disease	3
Hypertension	3

Condition MeSH

Condition MeSH for ULORIC
Intervention	Trials
Gout	9
Hyperuricemia	9
Renal Insufficiency, Chronic	3
Kidney Diseases	3

Clinical Trial Locations for ULORIC

Trials by Country

Trials by Country for ULORIC
Location	Trials
United States	276
Mexico	8
Canada	6
China	3
Iceland	1

Trials by US State

Trials by US State for ULORIC
Location	Trials
Texas	11
California	11
Florida	10
North Carolina	9
Oklahoma	8

Clinical Trial Progress for ULORIC

Clinical Trial Phase

Clinical Trial Phase for ULORIC
Clinical Trial Phase	Trials
Phase 4	5
Phase 3	6
Phase 2	11

Clinical Trial Status

Clinical Trial Status for ULORIC
Clinical Trial Phase	Trials
Completed	23
Terminated	2
Unknown status	1

Clinical Trial Sponsors for ULORIC

Sponsor Name

Sponsor Name for ULORIC
Sponsor	Trials
Takeda	15
Shanghai 10th People's Hospital	2
PAREXEL Early Phase Clinical Unit Baltimore	1

Sponsor Type

Sponsor Type for ULORIC
Sponsor	Trials
Industry	20
Other	19
NIH	1